Intriguingly, we found that tumor samples from patients with invasive breast carcinoma exhibited significantly lower PSMB2 and PSMB5 proteasome subunit mRNA expression compared to samples derived from normal tissue (Figure 4A). This evidence concerns the gene PSMB2 and neoplasm.